Schiff Hardin LLP served as legal counsel to Altaris Capital Partners in connection with an Altaris affiliate’s acquisition of Analogic Corporation for approximately $1.1 billion. The deal closed in June 2018.
Analogic is a leader in advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Analogic's ultrasound systems, led by its BK Ultrasound brand and used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical practitioners. Analogic's advanced imaging technologies are also used in computed tomography, magnetic resonance imaging and digital mammography systems, as well as automated threat detection systems for aviation security.
Altaris is a private equity firm focused on the global health care industry. Altaris actively manages $2.4 billion of equity capital and seeks to invest in businesses that deliver value to the health care system by improving patient outcomes, reducing costs, increasing efficiency and aligning stakeholder incentives. Since inception in 2003, Altaris has made 34 platform investments.